Idenix Pharmaceuticals Inc (NASDAQ:IDIX) Investor Alert: Lawsuit Filed to Halt the Takeover by Merck

San Diego, CA -- (SBWIRE) -- 06/24/2014 -- An investor, who currently holds shares of Idenix Pharmaceuticals Inc (NASDAQ:IDIX) filed a lawsuit in effort to halt the takeover of Idenix Pharmaceuticals Inc . by Merck for $24.50 per share.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.